Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Thyroid : Official Journal of the American Thyroid Association|August 24, 2004
Nondiabetic ketoacidosis caused by severe hyperthyroidismEmily T Wood, William B KinlawCancer Investigation|February 9, 2008
The synthetic triterpenoid CDDO-Im inhibits fatty acid synthase expression and has antiproliferative and proapoptotic effects in human liposarcoma cellsDavid T Hughes, Peter M Martel, William B Kinlaw, et al.International Journal of Clinical and Experimental Pathology|January 30, 2018
Inverse association between MDM2 and HUWE1 protein expression levels in human breast cancer and liposarcomaKaleigh Canfield, Wendy Wells, Joseph Geradts, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 12, 2010
Unusual recurrence of hypercalcemia due to concurrent parathyroid adenoma and parathyroid sarcoidosis with lymph node involvementLeila Chaychi, Sushela Chaidarun, Allan Golding, et al.Progress in Lipid Research|September 5, 2013
Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acidsNousheen Zaidi, Leslie Lupien, Nancy B Kuemmerle, et al.Endocrinology|July 1, 2006
Spot 14: A marker of aggressive breast cancer and a potential therapeutic targetWilliam B Kinlaw, Jennifer L Quinn, Wendy A Wells, et al.Journal of Cellular Physiology|February 5, 2016
Fatty Acids and Breast Cancer: Make Them on Site or Have Them DeliveredWilliam B Kinlaw, Paul W Baures, Leslie E Lupien, et al.Nutrition and Cancer|January 1, 2009
Conjugated linoleic acid (CLA) inhibits expression of the Spot 14 (THRSP) and fatty acid synthase genes and impairs the growth of human breast cancer and liposarcoma cellsChristina Donnelly, Arne M Olsen, Lionel D Lewis, et al.Breast Cancer Research and Treatment|March 23, 2006
Expression of "Spot 14" (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular markerWendy A Wells, Gary N Schwartz, Peter M Morganelli, et al.Journal of Hematopathology|May 5, 2015
FASN and CD36 predict survival in rituximab-treated diffuse large B-cell lymphomaOlga V Danilova, Larry J Dumont, Norman B Levy, et al.Pageof 3